市場調査レポート

商品コード

1429021

オーソバイオロジクスの世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Orthobiologics Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月20日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 228 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のオーソバイオロジクスの市場規模は、2023年の70億1,000万米ドルから2031年に112億4,000万米ドルに達し、予測期間の2024年～2031年にCAGRで6.08%の成長が見込まれています。市場は主に技術改良によって牽引されています。生体材料や手術方法の改良など、医療技術の進歩により、オーソバイオロジクスソリューションがより広く利用できるようになっています。骨や関節の問題をより効果的に治療する能力は、この進歩によって可能となり、その結果、患者にとっても医師にとっても、オーソバイオロジクスのオプションがより魅力的なものとなっています。

世界のオーソバイオロジクス市場は、世界の高齢化によって拡大しています。長生きする人ほど、骨粗鬆症や関節炎といった加齢に関連した整形外科的問題を経験する可能性が高くなります。高齢者に広く見られる骨折や変性疾患の治癒プロセスを促進するために頻繁に利用されるオーソバイオロジクスによる治療へのニーズは、この人口動態の変化によって高まっています。

世界のオーソバイオロジクス市場は、若年層や活動的な人々を含むあらゆる年齢層で整形外科的問題が増加しているため成長しています。ライフスタイルの選択に関連した筋骨格系の問題やスポーツ関連傷害の増加により、オーソバイオロジクスによる治療を必要とする患者が増加しています。

さらに、世界のオーソバイオロジクス市場の力学は、より侵襲性の低い手術ソリューションへの要望の高まりの影響を受けています。オーソバイオロジクスは低侵襲手術に頻繁に利用されており、これには回復時間の短縮、感染の可能性の低下、術後疼痛の減少などの利点があります。オーソバイオロジクスは、より低侵襲な技術へのシフトのために、手術、特にスポーツ医療の外科手術でより広く使用されています。

例えばTetrous, Inc.は2023年7月、スポーツ医療の外科手術に使用するEnfix（TM）Demineralized Bone Fibre Implantの米国特許を取得したと発表しました。EnFixファミリーの最初の製品であるEnFix RCは、腱板修復術専用に設計されたインプラントです。現在、EnFix RCが使用可能なのはオーストラリアと米国のみです。

整形外科疾患の急増が市場を後押し

世界の整形外科疾患有病率の上昇により、世界のオーソバイオロジクス市場は急成長しています。骨粗鬆症、関節炎、脊椎疾患などの症状を経験する人が増えており、効率的な治療ソリューションに対する需要が高まっています。骨の修復と再生を促進するオーソバイオロジクスは、これらの疾患の治療に不可欠です。これらの治療法の必要性は、現代のライフスタイルがもたらす筋骨格系の問題やスポーツ傷害の増加によってさらに高まっています。市場は健康への関心の高まりのために拡大しており、その結果、さまざまな整形外科的問題に対するより精巧で効果的なソリューションを生み出すための研究開発が推進されています。

『The Lancet Rheumatology』誌で発表された近年の研究によると、今後30年間で関節、筋肉、骨の問題が115％増加します。2050年までに、筋肉、骨、関節、靭帯、腱、脊椎の疾患を患う人々は世界で10億人を超えると思われます。COVID-19パンデミックの影響は、こうした予測において重要な役割を果たしている可能性があります。

市場を後押しする技術の進歩

技術の進歩は、特により効果的な新製品や治療法という形で、世界のオーソバイオロジクス市場の成長に大きな役割を果たしています。骨や関節の問題に対する治療は、生体材料や生物学的療法の発展により、より成功しやすくなっています。例えば、組織工学と再生医療の改善により、整形外科手術に不可欠なスキャフォールドや骨移植の質が向上しました。また、3Dプリンティング技術の進歩により、整形外科用器具やインプラントを患者それぞれのニーズに合わせてカスタマイズすることも可能になっています。患者の転帰を改善するだけでなく、こうした技術の進歩によって治療できる疾患の範囲が広がり、世界のオーソバイオロジクス市場が成長します。

当レポートでは、世界のオーソバイオロジクス市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

市場規模と予測
- 金額
- 数量
製品別
- 脱灰骨基質（DBM）
- 関節内補充薬
- 合成代用骨
- 同種移植片
- 骨成長因子
- その他
用途別
- 再建手術・骨折手術
- 変形性関節症
- 脊椎固定
- 軟部組織修復
- 顎顔面・歯科
- その他
エンドユーザー別
- 病院
- 外来・外傷ケアセンター
- 整形外科クリニック
- 歯科クリニック・施設
- その他
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
市場シェア：企業別（2023年）

第5章世界のオーソバイオロジクス市場の見通し：地域別（2017年～2031年）

北米
- 市場規模と予測
- 製品別
- 用途別
- エンドユーザー別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
南米
- ブラジル
- アルゼンチン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第6章市場マッピング（2023年）

製品別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸出入の分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第9章主要企業情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社の市場収益分析（2023年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場参入企業5社）
特許分析（該当する場合）

第10章価格分析

第11章ケーススタディ

第12章主要企業の見通し

Stryker Corporation
Johnson & Johnson
Zimmer Biomet Holdings Inc.
Arthrex, Inc.
Wright Medical Group N.V.
Integra Lifesciences Holdings Corporation
Globus Medical Inc.
Medline Industries Inc.
Bioventus Inc.
Exactech Inc.

第13章戦略的推奨事項

第14章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 3. Global Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 4. Global Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 5. Global Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 6. Global Orthobiologics Market Share (%), By Region, 2017-2031F
Figure 7. North America Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 9. North America Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 10. North America Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 11. North America Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 12. North America Orthobiologics Market Share (%), By Country, 2017-2031F
Figure 13. United States Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 15. United States Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 16. United States Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 17. United States Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 20. Canada Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 21. Canada Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 22. Canada Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 25. Mexico Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 26. Mexico Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 30. Europe Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 31. Europe Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 32. Europe Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Orthobiologics Market Share (%), By Country, 2017-2031F
Figure 34. Germany Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 36. Germany Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 37. Germany Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 38. Germany Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 39. France Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 41. France Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 42. France Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 43. France Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 46. Italy Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 47. Italy Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 48. Italy Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 51. United Kingdom Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 52. United Kingdom Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 56. Russia Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 57. Russia Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 58. Russia Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 61. Netherlands Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 62. Netherlands Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 66. Spain Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 67. Spain Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 68. Spain Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 71. Turkey Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 72. Turkey Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 76. Poland Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 77. Poland Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 78. Poland Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 79. South America Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 81. South America Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 82. South America Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 83. South America Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 84. South America Orthobiologics Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 87. Brazil Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 88. Brazil Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 92. Argentina Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 93. Argentina Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 97. Asia-Pacific Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 98. Asia-Pacific Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Orthobiologics Market Share (%), By Country, 2017-2031F
Figure 101. India Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 103. India Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 104. India Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 105. India Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 106. China Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 108. China Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 109. China Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 110. China Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 113. Japan Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 114. Japan Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 115. Japan Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 118. Australia Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 119. Australia Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 120. Australia Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 123. Vietnam Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 124. Vietnam Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 128. South Korea Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 129. South Korea Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 133. Indonesia Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 134. Indonesia Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 138. Philippines Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 139. Philippines Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 143. Middle East & Africa Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 144. Middle East & Africa Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Orthobiologics Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 149. Saudi Arabia Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 150. Saudi Arabia Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 154. UAE Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 155. UAE Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 156. UAE Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Orthobiologics Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
Figure 159. South Africa Orthobiologics Market Share (%), By Product, 2017-2031F
Figure 160. South Africa Orthobiologics Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Orthobiologics Market Share (%), By End-user, 2017-2031F
Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11017

Global orthobiologics market is projected to witness a CAGR of 6.08% during the forecast period 2024-2031, growing from USD 7.01 billion in 2023 to USD 11.24 billion in 2031. The global orthobiologics market is mostly driven by technological improvements. Orthobiologic solutions are now more widely available, thanks to advancements in medical technology, including improved biomaterials and surgical methods. The ability to treat bone and joint problems more effectively is being made possible by this advancement, which makes orthobiologic choices more appealing to patients and physicians alike.

The global orthobiologics market is expanding due to the ageing of the world's population. People who live longer are more likely to experience age-related orthopedic problems like osteoporosis and arthritis. The need for orthobiologic therapies, which are frequently utilized to accelerate the healing process for fractures and degenerative diseases that are widespread among the elderly, is increased by this shift in demography.

The global orthobiologics market is growing due to an increase in orthopedic problems across all age categories, including younger and more active people. An increasing number of patients require orthobiologic therapy due to the rise in musculoskeletal problems and sports-related injuries linked to lifestyle choices.

Furthermore, the dynamics of the global orthobiologics market is influenced by the growing desire for less intrusive surgical solutions. Orthobiologics are frequently utilized in minimally invasive operations; its benefits include shortened recovery times, a lower chance of infection, and decreased postoperative pain. Orthobiologic products are being more widely used in operations, particularly sports medicine surgical procedures, because of the shift towards less intrusive techniques.

Tetrous, Inc., for example, announced in July 2023 the issuance of a U.S. patent for Enfix(TM) Demineralized Bone Fibre Implants for use in sports medicine surgical operations. The first product in the EnFix family, EnFix RC, is an implant designed specifically for rotator cuff repair procedures. Australia and the United States are the only countries where it is now accessible.

Surge in Orthopedic Disorders Boosting the Market

The global orthobiologics market is growing rapidly due to the rising prevalence of orthopedic disorders worldwide. More people are experiencing conditions, including osteoporosis, arthritis, and spinal problems, which increases the demand for efficient treatment solutions. By encouraging bone repair and regeneration, orthobiologics is critical in treating these conditions. The need for these therapies is further increased by the rise in musculoskeletal issues and sports injuries brought on by contemporary lifestyles. The global orthobiologics market is expanding because of the rise in health concerns, which, in turn, is driving research and development efforts to produce more sophisticated and efficacious solutions for various orthopedic problems.

According to a recent study published in 'The Lancet Rheumatology' journal, there will be a 115 percent increase in problems of the joints, muscles, and bones during the next thirty years. By 2050, more than a billion people worldwide will likely be suffering from illnesses of the muscles, bones, joints, ligaments, tendons, and spine-a number that has increased from roughly half a billion in 2020. The impact of the Covid pandemic on our musculoskeletal system may play a significant role in these predictions.

Technological Advancements Fueling the Market

Technological advancements play a major role in the growth of the global orthobiologics market, particularly in the form of new and more effective products and treatment methods. Treatments for problems with the bones and joints are now more successful because of developments in biomaterials and biological therapies. For instance, improvements in tissue engineering and regenerative medicine have raised the calibre of scaffolds and bone transplants that are essential for orthopedic procedures. Advances in 3D printing technology also allow for customized orthopedic devices and implants, made to fit each patient's unique needs. In addition to improving patient outcomes, these technological advancements broaden the range of illnesses that can be treated, which grows the global orthobiologics market.

For instance, leading medical technology business, Xenco Medical showcased its TrabeculeX Continuum at the 2024 Consumer Electronics Show in Las Vegas, Nevada, on January 11th, showing its convergent technology that bridges biomaterials and digital health. The TrabeculeX Continuum, which integrates the TrabeculeX Bioactive Matrix and the TrabeculeX Recovery App, is the first technologically enabled link between digital health and orthobiologics, streamlining a patient's postoperative course and biomaterial implantation.

Growing Demand for Orthobiologics in Spinal Fusion Surgeries

Orthopedics use in spinal fusion procedures is a major driver of the global orthobiologics market. In joining two or more spinal vertebrae, orthobiologic materials, such as demineralized bone matrices, bone transplants, and bone morphogenetic proteins, play a critical role in spinal fusion. They lead to better patient outcomes and healing by dramatically improving the bone development and healing required for a successful fusion. The number of spinal fusion operations rises because of the rising incidence of spinal diseases, which are linked to factors including an aging population and unproductive lifestyles. The increase in surgeries is driving the demand for orthobiologic products, which, in turn, is propelling the growth and development of the global orthobiologics market.

For example, the UK-based orthobiologics company Locate Bio announced in May 2023 that LDGraft had received a breakthrough product classification from the US Food and Drug Administration (FDA). LDGraft is developed for anterior lumbar interbody spinal fusion (ALIF) procedures conducted at one level, from L3 to S1, for patients with degenerative disc disease.

The Growing Popularity of Demineralized Bone Matrix

The global orthobiologics market is growing due to the escalating demand for demineralized bone matrix (DBM). DBM is becoming increasingly well-liked because it works well for various orthopedic procedures, including spinal fusion, bone fractures, and joint reconstructions. DBM is a processed type of allograft bone that keeps growth factors essential for bone regeneration. DBM is becoming more popular due to its ability to stimulate bone growth and to work well with other grafts to enhance results. Thus, the growing demand for DBM in orthopedic surgeries is a major driver for the growth of the global orthobiologics market and illustrates the changing landscape of surgical bone healing techniques.

For instance, the full market release and initial implant of Legacy Demineralized Bone Matrix (DBM), a putty for repairing spaces or gaps in bony defects or traumatic injuries of the spine, pelvis, or extremities, were announced in October 2022 by Orthofix Medical Inc., a multinational medical device company with a focus on spine and orthopedics.

North America Dominates the Market

Numerous important variables are responsible for North America's dominant position in the global orthobiologics market. The area is home to a state-of-the-art healthcare system that stimulates substantial medical research and development, particularly in orthopedics. When combined with a significant investment in healthcare and a dedication to innovation, these features improve its position in the market. Orthobiologic treatments are highly needed due to the high prevalence of orthopedic disorders in North America, which are caused by an ageing population, increasing obesity rates, and lifestyle-related musculoskeletal problems. The strict regulatory environment in the area also guarantees the supply of safe and high-quality orthobiologic products, which propels the growth of the global orthobiologics market.

For example, in August 2022, CGBio, a firm that develops novel synthetic bone grafts, and Orthofix Medical Inc., a multinational medical device company focused on spine and orthopedics, signed a strategic cooperation arrangement. The two businesses collaborated to develop Novosis's recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials. They also aim to create other tissue regenerative solutions for the American and Canadian markets.

Future Market Scenario (2024 - 2031F)

The global orthobiologics market is poised for growth, influenced by the aging global population, a rise in orthopedic conditions, and breakthroughs in orthobiologic technologies.

The future of the global orthobiologics market is expected to be shaped by continuous research and development efforts, paving the way for the introduction of innovative and more efficient orthobiologic solutions, including cutting-edge biomaterials and regenerative medicine.

With the improvement of healthcare systems in emerging countries, the adoption of orthobiologic treatments in these areas is expected to rise, significantly contributing to the market's expansion.

Potential changes in government regulations and health insurance reimbursement policies could significantly influence the market, impacting the usage and accessibility of orthobiologic treatments and products.

Key Players Landscape and Outlook

One of the key factors driving the growth of the global orthobiologics market is the current noteworthy rise in mergers and acquisitions (M&A). Larger organisations are acquiring smaller or equivalent businesses through M&A transactions in order to expand their product offerings, break into new markets, and gain access to cutting-edge research and technology. Companies can increase their competitive edge, boost market presence, and achieve cost efficiency through these strategic consolidations. Furthermore, the combination of information and resources encourages creativity, which produces better orthobiologic products. Therefore, M&A activity plays a crucial role in shaping the market environment and promoting a more diverse and technologically advanced orthobiologics industry.

For example, in November 2023, Berkeley Biologics-a fully owned subsidiary of GNI Group-completed the acquisition of Elutia's Orthobiologics business unit for up to $35 million in cash. At closing, Elutia received a $15 million upfront payment, with additional earnout payments of up to $20 million possible over the next five years. Through the acquisition, Elutia hopes to give doctors access to the potency of targeted therapies, along with the advantages of natural biological materials for wound healing.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Orthobiologics Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product
- 4.2.1. Demineralized Bone Matrix (DBM)
- 4.2.2. Viscosupplements
- 4.2.3. Synthetic Bone Substitutes
- 4.2.4. Allografts
- 4.2.5. Bone Growth Factors
- 4.2.6. Others
4.3. By Application
- 4.3.1. Reconstructive & Fracture Surgery
- 4.3.2. Osteoarthritis & Degenerative Arthritis
- 4.3.3. Spinal Fusion
- 4.3.4. Soft Tissue Repair
- 4.3.5. Maxillofacial & Dental
- 4.3.6. Others
4.4. By End-user
- 4.4.1. Hospitals
- 4.4.2. Ambulatory & Trauma Care Centers
- 4.4.3. Orthopedic Clinics
- 4.4.4. Dental Clinics & Facilities
- 4.4.5. Others
4.5. By Region
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia-Pacific
- 4.5.4. South America
- 4.5.5. Middle East and Africa
4.6. By Company Market Share (%), 2023

5. Global Orthobiologics Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product
  - 5.1.2.1. Demineralized Bone Matrix (DBM)
  - 5.1.2.2. Viscosupplements
  - 5.1.2.3. Synthetic Bone Substitutes
  - 5.1.2.4. Allografts
  - 5.1.2.5. Bone Growth Factors
  - 5.1.2.6. Others
- 5.1.3. By Application
  - 5.1.3.1. Reconstructive & Fracture Surgery
  - 5.1.3.2. Osteoarthritis & Degenerative Arthritis
  - 5.1.3.3. Spinal Fusion
  - 5.1.3.4. Soft Tissue Repair
  - 5.1.3.5. Maxillofacial & Dental
  - 5.1.3.6. Others
- 5.1.4. By End-user
  - 5.1.4.1. Hospitals
  - 5.1.4.2. Ambulatory & Trauma Care Centers
  - 5.1.4.3. Orthopedic Clinics
  - 5.1.4.4. Dental Clinics & Facilities
  - 5.1.4.5. Others
- 5.1.5. United States*
  - 5.1.5.1. Market Size & Forecast
  - 5.1.5.1.1. By Value
  - 5.1.5.1.2. By Volume
  - 5.1.5.2. By Product
  - 5.1.5.3. Demineralized Bone Matrix (DBM)
  - 5.1.5.4. Viscosupplements
  - 5.1.5.5. Synthetic Bone Substitutes
  - 5.1.5.6. Allografts
  - 5.1.5.7. Bone Growth Factors
  - 5.1.5.8. Others
  - 5.1.5.9. By Application
  - 5.1.5.9.1. Metal-On-Metal
  - 5.1.5.9.2. Metal-On-Polyethylene
  - 5.1.5.9.3. Ceramic-On-Metal
  - 5.1.5.9.4. Ceramic-On-Polyethylene
  - 5.1.5.9.5. Ceramic-On-Ceramic
  - 5.1.5.10. By End-user
  - 5.1.5.10.1. Hospitals & Surgical Centers
  - 5.1.5.10.2. Ambulatory & Trauma Care Centers
  - 5.1.5.10.3. Orthopedic Clinics
  - 5.1.5.10.4. Home Care Settings
  - 5.1.5.10.5. Others
- 5.1.6. Canada
- 5.1.7. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product
6.2. By Application
6.3. By End-user
6.4. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Key Players Landscape

9.1. Competition Matrix of Top Five Market Leaders
9.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
9.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
9.4. SWOT Analysis (For Five Market Players)
9.5. Patent Analysis (If Applicable)

10. Pricing Analysis

11. Case Studies

12. Key Players Outlook

12.1. Stryker Corporation
- 12.1.1. Company Details
- 12.1.2. Key Management Personnel
- 12.1.3. Products & Services
- 12.1.4. Financials (As reported)
- 12.1.5. Key Market Focus & Geographical Presence
- 12.1.6. Recent Developments
12.2. Johnson & Johnson
12.3. Zimmer Biomet Holdings Inc.
12.4. Arthrex, Inc.
12.5. Wright Medical Group N.V.
12.6. Integra Lifesciences Holdings Corporation
12.7. Globus Medical Inc.
12.8. Medline Industries Inc.
12.9. Bioventus Inc.
12.10. Exactech Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

オーソバイオロジクスの世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Orthobiologics Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のオーソバイオロジクス市場の見通し（2017年～2031年）

第5章世界のオーソバイオロジクス市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章主要企業情勢

第10章価格分析

第11章ケーススタディ

第12章主要企業の見通し

第13章戦略的推奨事項

第14章当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Orthobiologics Market Outlook, 2017-2031F

5. Global Orthobiologics Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Key Players Landscape

10. Pricing Analysis

11. Case Studies

12. Key Players Outlook

13. Strategic Recommendations

14. About Us & Disclaimer

オーソバイオロジクスの世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Orthobiologics Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のオーソバイオロジクス市場の見通し（2017年～2031年）

第5章 世界のオーソバイオロジクス市場の見通し：地域別（2017年～2031年）

第6章 市場マッピング（2023年）

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 主要企業情勢

第10章 価格分析

第11章 ケーススタディ

第12章 主要企業の見通し

第13章 戦略的推奨事項

第14章 当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Orthobiologics Market Outlook, 2017-2031F

5. Global Orthobiologics Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Key Players Landscape

10. Pricing Analysis

11. Case Studies

12. Key Players Outlook

13. Strategic Recommendations

14. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のオーソバイオロジクス市場の見通し（2017年～2031年）

第5章世界のオーソバイオロジクス市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章主要企業情勢

第10章価格分析

第11章ケーススタディ

第12章主要企業の見通し

第13章戦略的推奨事項

第14章当社について、免責事項